Generate a tailored SOP for Dr. Hans Schreiber. Improve your application with a focused, well-structured draft.
Dr. Hans Schreiber is a Professor in the Department of Pathology at the University of Chicago. He specializes in studying the fundamental mechanisms that govern the interaction between cancer cells and the immune system. His research focuses on the exploitation of cancer-specific mutations in antigens to develop new therapies that help the immune system target and destroy cancer cells. He aims to understand how immunogenic cancer cells evade immune destruction and seeks to innovate strategies based on these principles for therapeutic advancement. Dr. Schreiber combines immunology with genetics and biochemistry to uncover cancer-specific changes in malignant cells, aiming to identify crucial immunological targets. His recent publications discuss the selection of therapeutically effective T-cell receptors and their role in controlling tumor progression as well as the systemic delivery of TGFß signaling inhibitors.
Department of Philosophy